About 200 reports

  • Revenue Breakdown (%), by Business Segment, 2016
  • Revenue Breakdown (%), by Business Segment, 2016

The lab automation market for in-vitro diagnostics was valued at USD 949.1 million in 2017, and is expected to reach a value of USD 1230.9 million by 2023 at a CAGR of 4.31%, over the forecast period (2018-2023).The scope of the report is limited to products offered by major players for various purposes which include Automated Plate Handler,...

  • Diagnostics
  • North America
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton Property Group
  • Infectious Diagnostics Market, United States, Company Share (%) 2017
  • Infectious Diagnostics Market, United States, Company Share (%) 2017 .................................................... 123

United States Infectious Diagnostics Market Outlook to 2024 Summary GlobalData’s new report, United States Infectious Diagnostics Market Outlook to 2024, provides key market data on the United States Infectious Diagnostics market. The report provides value, in millions of US dollars, volume (in units)...

  • Diagnostics
  • North America
  • Alere Inc.
  • bioMerieux S.A.
  • DiaSorin S.p.A.
  • INFECTIOUS DIAGNOSTICS MARKET, MEXICO, COMPANY SHARE (%) 2017
  • DILON DIAGNOSTICS ENTERS INTO DISTRIBUTION AGREEMENT WITH GE HEALTHCARE IN NORTH AMERICA

Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary GlobalData’s new report, Mexico In Vitro Diagnostics (IVD) Market Outlook to 2024, provides...

  • Diagnostics
  • North America
  • Forecast
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Molecular Diagnostics Market: Revenue in USD million, by Application, Canada, 2017-2022
  • Molecular Diagnostics Market: Revenue in USD million, by In Situ Hybridization, North America,

Molecular Diagnostics Market The market was valued at USD 6 billion in 2015 and is expected to grow to USD 6.58 in 2016 and USD 9.53 billion by 2021, at a CAGR of 9.7%. Molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions,...

  • Diagnostics
  • North America
  • Market Size
  • Cepheid
  • Roche Group
  • In-vitro Diagnostics Market: Revenue in USD billion, POC Diagnostics, United States, 2018-2023
  • In-vitro Diagnostics Market: Revenue in USD billion, Tissue Diagnostics, United States, 2018-2023

The US in-vitro diagnostics market has been estimated at USD 13.57 billion in 2017 and is expected to register a CAGR of 5.57% during the forecast period, 2018 to 2023. Due to increasing incidences of chronic diseases and rapid adoption of point-of-care testing, along with increasing preference for personalized medicine, the in-vitro diagnostics...

  • Diagnostics
  • North America
  • Becton Property Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ROCHE DIAGNOSTICS REVENUE (2012Ͳ2015) ($ MILLIONS)
  • U.S. MOLECULAR DIAGNOSTICS MARKET (2015/2020) ($ MILLIONS)

United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S....

  • Diagnostics
  • North America
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group
  • United States - Forecast for Molecular Diagnostics Application Market Share (Percent), 2017 -
  • United States - Molecular Diagnostics Application Market Share (Percent), 2010 - 2016

By 2024, United States molecular diagnostics market is expected to cross US$ 9 billion. Main factors pouring the growth of molecular diagnostics market are increased incidence of infectious diseases and different types of cancer. On the other hand, advancement of new technologies in the field of medicine and research fuels the molecular diagnostics...

  • Diagnostics
  • North America
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.

Tissue Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024 Section ## Preface ##. ## Report Scope and Market Segmentation ##. ## Research Highlights Section-## Assumptions and Research Methodology ##. ## Assumptions and Acronyms Used ##. ## Resea

  • Diagnostics
  • APAC
  • North America
  • World
  • Market Size

List of Tables Table ## Global Allergy Diagnostics Market Outlook, By Region (2014-2023) ($MN) Table ## Global Allergy Diagnostics Market Outlook, By Product & Service (2014-2023) ($MN) Table ## Global Allergy Diagnostics Market Outlook, By Assay Kits (2014-2023)

  • Diagnostics
  • APAC
  • North America
  • Forecast
  • Market Size

List of Tables Table ## Global Poultry Diagnostics Market Outlook, By Region (2014-2023) ($MN) Table ## Global Poultry Diagnostics Market Outlook, By Test Type (2014-2023) ($MN) Table ## Global Poultry Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) Te

  • Diagnostics
  • Africa
  • North America
  • Forecast
  • Market Size

Critical Care Diagnostics - Global Market Outlook (2017-2023) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Prim

  • Diagnostics
  • Intensive Care
  • North America
  • Forecast
  • Market Size

Hospital - Acquired Infection (HAI) Diagnostics Market - Global Market Size, Share, Development, Growth, and Demand Forecast, 2016 - 2023 Chapter ##.

  • Diagnostics
  • Health Services
  • Hospital
  • North America
  • Market Size

Global Animal Therapeutics and Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Strategic Benchmarking ##. ## Opportuni

  • Diagnostics
  • Therapy
  • North America
  • Forecast
  • Market Size
  • 6.7 Becton Dickinson - United States Molecular Diagnostic Sales and
  • ABBOTT LABORATORIES - UNITED STATES MOLECULAR DIAGNOSTIC SALES (MILLION US$), 2010 - 2014

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. The United States is the key market for molecular diagnostics...

  • Diagnostics
  • North America
  • Cepheid
  • Myriad Genetics, Inc.
  • QIAGEN N.V.

Global Molecular Diagnostics Market (2016 - 2022) Table of Contents: Global Molecular Diagnostics Market Chapter ##.

  • Diagnostics
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • North America
  • Market Size

Global DNA Diagnostics Market (2016-2022) Table of Contents Chapter ##.

  • Diagnostics
  • APAC
  • North America
  • World
  • Market Size

Global Transfusion Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Application Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analy

  • Diagnostics
  • APAC
  • North America
  • Forecast
  • Market Size
  • Personalized medicine Companion diagnostics
  • ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2016)

“Global cancer biomarkers market projected to grow at CAGR of 12.2%” The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence...

  • Diagnostics
  • North America
  • Market Size
  • QIAGEN N.V.
  • Roche Group
  • Microbiome Therapeutics and Diagnostics Investments: Amount
  • MICROBIOME DIAGNOSTICS: DISTRIBUTION BY GEOGRAPHICAL LOCATION

INTRODUCTION Microbiome therapeutics represent a new frontier in the field of medicine. The human microbiome is characterized by more than 100 trillion commensal, symbiotic and pathogenic microorganisms that colonize the gut, mouth, skin and various other parts of the body. Majority of these microorganisms benefit humans by supplementing...

  • Diagnostics
  • Pharmaceutical
  • North America
  • Market Size
  • MicroBiome Therapeutics LLC

(BD) ##. ## bioMérieux ##. ## Bio-Rad Laboratories ##. ## Bruker Corporation ##. ## Cepheid ##. ## Chembio Diagnostic Systems ##. ## Nanosphere, Inc. ##. ## Ortho-Clinical Diagnostics ##. ## Roche Diagnostics ##. ## Siemens Healthcare Diagnostics ##. ## T## Biosystems, Inc. ##. ##

  • Blood Disease
  • Diagnostics
  • APAC
  • North America
  • Market Size
  • NON-INVASIVE CANCER DIAGNOSTICS MARKET (USD BILLION), 2017, 2023 AND 2030
  • NON-INVASIVE CANCER DIAGNOSTICS MARKET (2017-2030): BASE SCENARIO (USD BILLION)

INTRODUCTION Cancer is an extremely complex disease and medical science is still struggling to figure out the reasons and factors that influence the disease origin, propagation, spread (metastasis) and relapse. In 2017, a total of 1.7 million new cancer cases are estimated to be diagnosed in the US alone; during the same time...

  • Diagnostics
  • North America
  • Market Size
  • Biocept, Inc.
  • Transgenomic, Inc.
  • BUSINESS REVENUE MIX
  • RECENT FINANCIALS (Diagnostics Segment)

The in situ hybridization market is projected to reach USD 739.9 million by 2021 from USD 557.1 million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are some...

  • Diagnostics
  • North America
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • RECENT FINANCIALS (DIAGNOSTICS DIVISION)
  • F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2017)

Microfluidics market is projected to grow at a CAGR of 22.6% The microfluidics market is projected to reach USD 27.91 billion by 2023 from estimated USD 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics...

  • Diagnostics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.

Expert Opinion on Medical Diagnostics; ##(##): ##-##.

  • Diagnostics
  • North America
  • Market Size
  • Alere Inc.
  • Roche Group
  • 7.4 SOFTWARE/INFORMATICS 7.4.1 DIAGNOSTICS
  • GLOBAL INSTRUMENTS MARKET FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD BILLION)

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Diagnostics
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.

Du Pont De Nemours and Company ##. ## Danaher Corporation ##. ## Bioconrtol Systems, Inc. ##. ## Biomérieux SA ##. ## Bio-Rad Laboratories, Inc. ##. ## ##M Company Table of Contents ## Global Food Diagnostics Systems Outlook, By Region (2013-2022) ($MN) ## Global Food

  • Diagnostics
  • APAC
  • North America
  • World
  • Market Size

Farm Animal Diagnostics - Global Market Outlook (2015-2022) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Prima

  • Diagnostics
  • APAC
  • North America
  • Forecast
  • Market Size
  • Net Sales (%), by Business Segment, 2017
  • Net Sales by Business Segment (%) - 2016

The global microfluidics market was valued at USD 4.552 billion in 2017, and is expected to reach USD 111.95 billion by 2023, recording a CAGR of 17.45% over the forecast period of 2018-2023. The scope of the report is limited to solutions offered by major players, including providers of microfluidic chips, micro pumps, and micro needles....

  • Diagnostics
  • Microfluidics
  • North America
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

North America Molecular Diagnostics Market (2016 - 2022) Table of Contents: North America Molecular Diagnostics Market Chapter ##.

  • Diagnostics
  • Molecular Diagnostic
  • North America
  • United States
  • Market Size

Strategic Initiatives List of Tables ##.

  • Diagnostic Imaging
  • Diagnostics
  • North America
  • United States
  • Market Size